• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估同伴支持性筛查作为囚犯丙型肝炎病例发现模式。

Evaluating peer-supported screening as a hepatitis C case-finding model in prisoners.

机构信息

Irish College of General Practitioners, Lincoln Place, Dublin 2, Ireland.

School of Medicine, University College Dublin, Dublin, Ireland.

出版信息

Harm Reduct J. 2019 Jul 5;16(1):42. doi: 10.1186/s12954-019-0313-7.

DOI:10.1186/s12954-019-0313-7
PMID:31277665
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6612120/
Abstract

BACKGROUND

Hepatitis C Virus (HCV) infection is endemic in prison populations, and HCV management in prisons is suboptimal. Incarceration is a public health opportunity to target this cohort. Community peer support increases HCV screening and treatment uptake. Prison peer workers have the potential to support the engagement of prisoners with health services and reduce stigma. This study's primary aim is to evaluate peer-supported screening as a model of active HCV case finding with a secondary aim to describe the HCV cascade among those infected including linkage to care and treatment outcomes.

METHODS

An observational study was conducted in a medium-security Irish male prison housing 538 inmates, using a risk-based questionnaire, medical records, peer-supported screening, laboratory-based HCV serology tests and mobile elastography.

RESULTS

A prison peer-supported screening initiative engaged large numbers of prisoners in HCV screening (n = 419). The mean age of participants was 32.8 years, 92% were Irish and 33% had a history of injecting drug use. Multiple risk factors for HCV acquisition were identified including needle sharing (16%). On serological testing, 87 (21%) were HCV Ab +ve and 50 (12%) were HCV RNA +ve of whom 80% were fibroscaned (25% showing evidence of liver disease). Eighty-six percent of those with active infection were linked with HCV care, with 33% undergoing or completing treatment. There was a high concordance with HCV disclosure at committal and serological testing (96% for HCV Ab +ve and 89% for HCV Ab -ve).

CONCLUSION

Peer-supported screening is an effective active HCV case-finding model to find and link prisoners with untreated active HCV infection to HCV care.

摘要

背景

丙型肝炎病毒(HCV)感染在监狱人群中流行,监狱内的 HCV 管理并不理想。监禁是针对这一人群的一个公共卫生机会。社区同伴支持可提高 HCV 筛查和治疗的参与率。监狱同伴工作者有潜力支持囚犯与卫生服务机构的接触,并减少耻辱感。本研究的主要目的是评估同伴支持的筛查作为一种主动 HCV 病例发现模式,次要目的是描述感染 HCV 的患者的 HCV 级联情况,包括与护理的联系和治疗结果。

方法

在一所容纳 538 名囚犯的中等安全级别的爱尔兰男子监狱中进行了一项观察性研究,使用基于风险的问卷、医疗记录、同伴支持的筛查、基于实验室的 HCV 血清学检测和移动弹性成像。

结果

一项监狱同伴支持的筛查计划使大量囚犯参与了 HCV 筛查(n=419)。参与者的平均年龄为 32.8 岁,92%是爱尔兰人,33%有注射吸毒史。确定了 HCV 感染的多种危险因素,包括共用针头(16%)。在血清学检测中,87(21%)例 HCV Ab +ve,50(12%)例 HCV RNA +ve,其中 80%进行了肝弹性成像(25%显示有肝脏疾病证据)。有活动感染的患者中有 86%与 HCV 护理相关联,其中 33%正在接受或完成治疗。在入院时和血清学检测时 HCV 的披露高度一致(HCV Ab +ve 为 96%,HCV Ab -ve 为 89%)。

结论

同伴支持的筛查是一种有效的主动 HCV 病例发现模式,可以发现和联系未接受治疗的有活动感染的 HCV 感染的囚犯,并将其与 HCV 护理联系起来。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/112d/6612120/067ac3e88a91/12954_2019_313_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/112d/6612120/c02e385d0605/12954_2019_313_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/112d/6612120/067ac3e88a91/12954_2019_313_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/112d/6612120/c02e385d0605/12954_2019_313_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/112d/6612120/067ac3e88a91/12954_2019_313_Fig2_HTML.jpg

相似文献

1
Evaluating peer-supported screening as a hepatitis C case-finding model in prisoners.评估同伴支持性筛查作为囚犯丙型肝炎病例发现模式。
Harm Reduct J. 2019 Jul 5;16(1):42. doi: 10.1186/s12954-019-0313-7.
2
The seroprevalence of untreated chronic hepatitis C virus (HCV) infection and associated risk factors in male Irish prisoners: a cross-sectional study, 2017.2017 年爱尔兰男性囚犯中未经治疗的慢性丙型肝炎病毒(HCV)感染的血清流行率及其相关危险因素:一项横断面研究。
Euro Surveill. 2019 Apr;24(14). doi: 10.2807/1560-7917.ES.2019.24.14.1800369.
3
Competing priorities and second chances - A qualitative exploration of prisoners' journeys through the Hepatitis C continuum of care.竞争的优先级和第二次机会——对囚犯通过丙型肝炎连续护理过程的定性探索。
PLoS One. 2019 Sep 11;14(9):e0222186. doi: 10.1371/journal.pone.0222186. eCollection 2019.
4
Barriers and facilitators to hepatitis C (HCV) screening and treatment-a description of prisoners' perspective.阻碍和促进丙型肝炎(HCV)筛查和治疗的因素——囚犯视角的描述。
Harm Reduct J. 2018 Dec 11;15(1):62. doi: 10.1186/s12954-018-0269-z.
5
Offering HCV treatment to prisoners is an important opportunity: key principles based on policy and practice assessment in Europe.向囚犯提供 HCV 治疗是一个重要的机会:基于欧洲政策和实践评估的关键原则。
BMC Public Health. 2019 Jan 8;19(1):30. doi: 10.1186/s12889-018-6357-x.
6
New hepatitis C virus infection, re-infection and associated risk behaviour in male Irish prisoners: a cohort study, 2019.2019年爱尔兰男性囚犯中的新型丙型肝炎病毒感染、再感染及相关风险行为:一项队列研究
Arch Public Health. 2021 Jun 8;79(1):97. doi: 10.1186/s13690-021-00623-2.
7
Evaluation of a prison outreach clinic for the diagnosis and prevention of hepatitis C: implications for the national strategy.评估一所监狱外展诊所对丙型肝炎的诊断和预防工作:对国家战略的启示
Gut. 2003 Oct;52(10):1500-4. doi: 10.1136/gut.52.10.1500.
8
Hepatitis C virus screening and treatment in Irish prisons from a governor and prison officer perspective - a qualitative exploration.从监狱长和狱警视角看爱尔兰监狱中的丙型肝炎病毒筛查与治疗——一项定性探索
Health Justice. 2018 Dec 19;6(1):23. doi: 10.1186/s40352-018-0081-6.
9
A framework for management of hepatitis C in prisons.监狱中丙型肝炎管理框架。
Ann Intern Med. 2006 May 16;144(10):762-9. doi: 10.7326/0003-4819-144-10-200605160-00010.
10
Risk factors for prevalent hepatitis C virus-infection among inmates in a state prison system in Mexico.墨西哥某州监狱系统内囚犯中丙型肝炎病毒现患感染的危险因素
PLoS One. 2017 Jun 27;12(6):e0179931. doi: 10.1371/journal.pone.0179931. eCollection 2017.

引用本文的文献

1
'You've Just Got to Keep Pestering': Barriers and Enablers of Attaining Continuity of Hepatitis C Care for People Transitioning Between Prison and Community Health Services in South-East Queensland, Australia.“你必须不断纠缠”:澳大利亚昆士兰州东南部在监狱和社区卫生服务之间过渡的人群获得丙型肝炎持续护理的障碍与促进因素
Int J Environ Res Public Health. 2025 Feb 7;22(2):238. doi: 10.3390/ijerph22020238.
2
Hepatitis C Care in the Greater New Orleans Area: Patient Perspectives on the Barriers and Facilitators to Care.大新奥尔良地区的丙型肝炎护理:患者对护理障碍和促进因素的看法。
J Health Care Poor Underserved. 2025;36(1):257-283. doi: 10.1353/hpu.2025.a951596.
3

本文引用的文献

1
Barriers and facilitators to hepatitis C (HCV) screening and treatment-a description of prisoners' perspective.阻碍和促进丙型肝炎(HCV)筛查和治疗的因素——囚犯视角的描述。
Harm Reduct J. 2018 Dec 11;15(1):62. doi: 10.1186/s12954-018-0269-z.
2
Treating HCV in a Captive Audience: Eradication Efforts in the Prison Microenvironment.在封闭环境中治疗 HCV:监狱微环境中的根除努力。
Am J Gastroenterol. 2018 Nov;113(11):1585-1587. doi: 10.1038/s41395-018-0201-x. Epub 2018 Jul 24.
3
Harm reduction and viral hepatitis C in European prisons: a cross-sectional survey of 25 countries.
Understanding Perceptions of Hepatitis C and Its Management Among People with Experience of Incarceration in Quebec, Canada: A Qualitative Study Guided by the Common Sense Self-Regulation Model.
了解加拿大魁北克省有监禁经历者对丙型肝炎及其管理的认知:一项以常识自我调节模型为指导的定性研究
Viruses. 2024 Dec 12;16(12):1910. doi: 10.3390/v16121910.
4
CHIME - A tailored HCV microelimination project in Viennese people who inject drugs at drug centralized substitution centers.CHIME——一项针对在毒品集中替代中心注射毒品的维也纳人的定制丙型肝炎微消除项目。
J Virus Erad. 2023 Jul 27;9(3):100338. doi: 10.1016/j.jve.2023.100338. eCollection 2023 Sep.
5
Monitoring progress towards elimination of hepatitis B and C in the EU/EEA.监测欧盟/欧洲经济区消除乙型和丙型肝炎的进展情况。
PLOS Glob Public Health. 2022 Aug 17;2(8):e0000841. doi: 10.1371/journal.pgph.0000841. eCollection 2022.
6
Falling treatment uptake in the hepatitis C care cascade is a growing threat to achieving elimination.治疗吸收率下降是丙型肝炎防治工作面临的一大威胁,若不加以应对,消除(丙型肝炎)的目标将难以实现。
J Viral Hepat. 2023 Jan;30(1):46-55. doi: 10.1111/jvh.13757. Epub 2022 Nov 2.
7
COVID-19 Vaccination Uptake and Related Determinants in Detained Subjects in Italy.意大利被拘留者中新冠疫苗接种情况及相关决定因素
Vaccines (Basel). 2022 Apr 23;10(5):673. doi: 10.3390/vaccines10050673.
8
COVID-19 vaccination in the Federal Bureau of Prisons, December 2020-April 2021.2020年12月至2021年4月联邦监狱管理局的新冠病毒疫苗接种情况
Vaccine. 2021 Sep 24;39(40):5883-5890. doi: 10.1016/j.vaccine.2021.08.045. Epub 2021 Aug 14.
9
Cost-effectiveness of mass screening for Hepatitis C virus among all inmates in an Irish prison.对爱尔兰监狱所有囚犯进行丙型肝炎病毒大规模筛查的成本效益。
Int J Drug Policy. 2021 Oct;96:103394. doi: 10.1016/j.drugpo.2021.103394. Epub 2021 Aug 17.
10
The impact of direct-acting antivirals on hepatitis C viraemia among people who inject drugs in England; real-world data 2011-2018.英格兰注射吸毒人群中直接作用抗病毒药物对丙型肝炎病毒血症的影响;2011-2018 年真实世界数据。
J Viral Hepat. 2021 Oct;28(10):1452-1463. doi: 10.1111/jvh.13575. Epub 2021 Jul 29.
减少危害和欧洲监狱中的丙型肝炎病毒:25 个国家的横断面调查。
Harm Reduct J. 2018 May 11;15(1):25. doi: 10.1186/s12954-018-0230-1.
4
Interventions to increase testing, linkage to care and treatment of hepatitis C virus (HCV) infection among people in prisons: A systematic review.监狱人群中丙型肝炎病毒(HCV)感染检测、关联护理和治疗的干预措施:系统评价。
Int J Drug Policy. 2018 Jul;57:95-103. doi: 10.1016/j.drugpo.2018.04.003. Epub 2018 Apr 30.
5
Hepcare Europe - bridging the gap in the treatment of hepatitis C: study protocol.《Hepcare Europe - 填补丙型肝炎治疗空白:研究方案》。
Expert Rev Gastroenterol Hepatol. 2018 Mar;12(3):303-314. doi: 10.1080/17474124.2018.1424541. Epub 2018 Jan 16.
6
'Beyond the willing & the waiting' - The role of peer-based approaches in hepatitis C diagnosis & treatment.“超越意愿与等待”——同伴支持方法在丙型肝炎诊断和治疗中的作用。
Int J Drug Policy. 2017 Dec;50:111-115. doi: 10.1016/j.drugpo.2017.08.004. Epub 2017 Sep 18.
7
Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs.针具交换计划和阿片类药物替代疗法预防注射吸毒者丙型肝炎传播
Cochrane Database Syst Rev. 2017 Sep 18;9(9):CD012021. doi: 10.1002/14651858.CD012021.pub2.
8
Universal opt-out screening for hepatitis C virus (HCV) within correctional facilities is an effective intervention to improve public health.在惩教机构内对丙型肝炎病毒(HCV)进行普遍的退出式筛查是一项改善公共卫生的有效干预措施。
Int J Prison Health. 2017 Sep 11;13(3-4):192-199. doi: 10.1108/IJPH-07-2016-0028.
9
Modelling the impact of incarceration and prison-based hepatitis C virus (HCV) treatment on HCV transmission among people who inject drugs in Scotland.模拟监禁及监狱内丙型肝炎病毒(HCV)治疗对苏格兰注射吸毒者中HCV传播的影响。
Addiction. 2017 Jul;112(7):1302-1314. doi: 10.1111/add.13783. Epub 2017 Mar 3.
10
Social capital strategies to enhance hepatitis C treatment awareness and uptake among men in prison.提高监狱男性丙型肝炎治疗意识和接受度的社会资本策略。
J Viral Hepat. 2017 Feb;24(2):111-116. doi: 10.1111/jvh.12627. Epub 2016 Oct 24.